ahlam1399
08-07-2015, 11:24 AM
BRIEF-Tigenix obtains FDA?s endorsement for its Cx601 phase III registration trial in the US
* An**unced has reached agreement with the U.S. Food and drug administration (FDA) on a special protocol assessment (SPA) for its phase III registration trial of Cx601 in the U.S. http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=YLukBmcZk_0:qE3POVAV-pE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=YLukBmcZk_0:qE3POVAV-pE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=YLukBmcZk_0:qE3POVAV-pE:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=YLukBmcZk_0:qE3POVAV-pE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=YLukBmcZk_0:qE3POVAV-pE:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/YLukBmcZk_0
* An**unced has reached agreement with the U.S. Food and drug administration (FDA) on a special protocol assessment (SPA) for its phase III registration trial of Cx601 in the U.S. http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=YLukBmcZk_0:qE3POVAV-pE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=YLukBmcZk_0:qE3POVAV-pE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=YLukBmcZk_0:qE3POVAV-pE:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=YLukBmcZk_0:qE3POVAV-pE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=YLukBmcZk_0:qE3POVAV-pE:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/YLukBmcZk_0